I was wondering if anyone had any recommendations for any new anti-depressant anti-anxiety meds. I've been on Lexapro for probably 10 years now and feel like it hasn't been working well for some time. Over the years I've tried just about everything. Effexor made me exhausted. I liked Zoloft but I put on 20 pounds and nothing else felt particularly effective. Not sure what to do but have not been feeling good for some time. I'd be so grateful for any suggestions!
I can recommend either Celexa which is in the same class as Lexapro and Zoloft or Cymbalta or Pristiq which are in the same class as Effexor. I take Pristiq for depression and anxiety. It has been very effective. It is an improved version of Effexor and does not make me tired.
I hear you, it's a long-suffering (patience) hit & miss thing, to recommend anything would't really make sense as what worked for me may very well turn out to be horrid for you. Best bet is a Dr that knows you well and your willingness to give and new meds at least 3-4 weeks. If you'e not already, having a group to fellowship with helps greatly as well, often times we put so much on the meds we forget how valuable that empathy can be. It helped me after years of hit & miss. Hope this helps.
I started taking viibryd about 3mts ago.and like you I have tried everything,nothing worked.till my head shrink as i call him,recommended this.and it has been a god send.i noticed a difference in 7 days.there is no weight gain as with other pills,actually I have lost 20 pounds in the last 2mts.so you might want to talk to your doc.about this one..good luck in your journey.
Subscribe to receive email notifications whenever new articles are published.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Oct 1st, 2018), Cerner Multum™ (updated Oct 2nd, 2018), Wolters Kluwer™ (updated Oct 2nd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.